What is the approximate market price of one injection of adalimumab?

Adalimumab is a humanized monoclonal antibody that is mainly used to treat a variety of autoimmune diseases, such as rheumatoid arthritis (RA), psoriasis, active psoriatic arthritis (PA), atopic dermatitis (AD), ulcerative colitis, Crohn's disease (CD), and ankylosing spondylitis. Adalimumab specifically binds to tumor necrosis factor alpha (TNF-α) to inhibit its activity, thereby reducing the inflammatory response and having a significant effect on improving patients' clinical symptoms and quality of life.

In terms of application, adalimumab is usually used in patients who have failed or have poor tolerance to other treatments. Such patients often experience long-term pain and suffering, and traditional treatment options fail to effectively control the disease. With the use of adalimumab, many patients have experienced significant improvement in their symptoms, and some have even achieved clinical remission. In addition, adalimumab is administered by subcutaneous injection, and patients can inject it themselves at home, which to a certain extent improves patient compliance and treatment convenience.

Regarding price, adalimumab is already on the market in China and is included in medical insurance, reducing the financial burden on patients. In overseas markets, the price of adalimumab generic drugs is usually higher. For example, the price of 40mg/0.4ml*2 tubes is more than 1,000 yuan. However, with the continuous advancement of my country's generic drug policy, some domestically produced adalimumab injections have appeared on the market, with prices that are relatively affordable, usually ranging from RMB 400 to RMB 800. These domestic generic drugs are basically the same as the original drugs in terms of ingredients and efficacy, allowing more patients to get the treatment they need.

In summary, adalimumab, as an important biological agent, plays an important role in the treatment of autoimmune diseases. With the popularization of drugs and medical insurance coverage, more and more patients will be able to benefit from this innovative treatment and improve their quality of life. At the same time, the emergence of generic drugs on the market has also provided patients with more choices and reduced their financial burden.

Reference materials:https://www.drugs.com/adalimumab.html